|
|
|
| Yu Liang1,* |
| Maximilian
Diehn3,* |
| Ken D. Aldape6 |
| M. Kelly Nicholas1 |
| Andrew W. Bollen2 |
| Kathleen R. Lamborn1 |
| Mitchel S. Berger1 |
| David Botstein4 |
| Patrick
O. Brown3,5,|| |
| Mark A. Israel1,+,|| |
1 Department of Neurological Surgery, Preuss
Laboratory for Molecular Neuro-Oncology, Brain Tumor
Research Center, University of California, San
Francisco, CA 94143
2 Department of Pathology, Preuss
Laboratory for Molecular Neuro-Oncology, Brain Tumor
Research Center, University of California, San
Francisco, CA 94143
3 Department of Biochemistry, Stanford University School of Medicine, Stanford CA 94305
4 Department of Genetics, Stanford University
School of Medicine, Stanford CA 94305
5 Howard Hughes Medical Institute, Stanford University School of
Medicine, Stanford CA 94305
6 Department of Pathology, Section of Neuropathology, University of Texas M. D. Anderson Cancer Center, TX 77030
*These authors contributed equally to this work
+To whom
correspondence should
be addressed
||Current address: Norris Cotton Cancer Center, Dartmouth Medical School, Lebanon, NH 03756
|
|